Cheuk H. Lau

State Key Laboratory Of Digestive Disease
Sar, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Dietary nitrate drives gastritis by modulating gastric microbiota and metabolites.

Dietary nitrate drives gastritis by modulating gastric microbiota and metabolites.

Journal: Cancer biology & medicine
Published: April 28, 2026

Targeting cancer stem cells enhances multikinase inhibitor therapy in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma.

Targeting cancer stem cells enhances multikinase inhibitor therapy in metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma.

Journal: Gut
Published: July 29, 2025

Gut microbiota in cancer initiation, development and therapy.

Gut microbiota in cancer initiation, development and therapy.

Journal: Science China. Life sciences
Published: December 03, 2024

Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy.

Hepatic TM6SF2 activates antitumour immunity to suppress metabolic dysfunction-associated steatotic liver disease-related hepatocellular carcinoma and boosts immunotherapy.

Journal: Gut
Published: June 21, 2024

Stomach microbiota in gastric cancer development and clinical implications.

Stomach microbiota in gastric cancer development and clinical implications.

Journal: Gut
Published: May 07, 2024

Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer.

Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer.

Journal: Pharmacological research
Published: May 01, 2024

Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase.

Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase.

Journal: Gut
Published: August 03, 2023

Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells.

Roseburia intestinalis generated butyrate boosts anti-PD-1 efficacy in colorectal cancer by activating cytotoxic CD8+ T cells.

Journal: Gut
Published: May 15, 2023

Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis.

Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1/Kyn/AHR axis.

Journal: Gut
Published: January 19, 2023

Uncovering novel human gut virome using ultra-deep metagenomic sequencing.

Uncovering novel human gut virome using ultra-deep metagenomic sequencing.

Journal: Chinese medical journal
Published: December 30, 2022

Gut microbiota and immune alteration in cancer development: implication for immunotherapy.

Gut microbiota and immune alteration in cancer development: implication for immunotherapy.

Journal: eGastroenterology
Published: November 20, 2022

Gut microbiota: impacts on gastrointestinal cancer immunotherapy.

Gut microbiota: impacts on gastrointestinal cancer immunotherapy.

Journal: Gut microbes
Published: January 13, 2021
Showing 1-12 of 18

Last Updated: 09/26/2026